{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4500, 
        4510
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4686, 
        4700
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4331, 
        4354
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5218, 
        5238
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4371, 
        4398
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4403, 
        4408
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5091, 
        5096
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5136, 
        5140
      ]
    }
  ], 
  "Lymphatic System Location (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4979, 
        4989
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5005, 
        5015
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        533, 
        562
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2740, 
        2775
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4951, 
        4977
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5060, 
        5086
      ]
    }
  ], 
  "Negative Findings Phraseology (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4476, 
        4510
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4592, 
        4626
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4489, 
        4499
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4677, 
        4685
      ]
    }
  ], 
  "Neoplasm Grade-Score Name (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4717, 
        4732
      ]
    }
  ], 
  "Neoplasm Score Value (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4734, 
        4741
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5031, 
        5039
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5180, 
        5188
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4517, 
        4519
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4634, 
        4636
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5088, 
        5090
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5133, 
        5135
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5177, 
        5179
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 11^9999^MOH|PIMS|CCO|20160503080126|26CBEEF199AD47B0772CFB3EBD11CA773C098FB3|ORU^R01|999999999999|P|2.5|||||||\nPID|1||G99999999^^^^CMR^HOSPITAL 11&9999&MOH~G99999999^^^^MRN^HOSPITAL 11&9999&MOH~9999999999&CM&^^^^JHN||XXXXXXX^XXXX^ XXXXX^^^^||99999999|M|||999 XXXXXX XXXXXX^^XXXXXX^XX^X9X 9X9^999|||||||||||||||||||N||||\nOBR|1||16:S3969|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||20160426|||87297^XXXXXXX^ XXXXXX^^^^||||||||||||20160502|||F|||||||99999^XXXXXXX^ XXXXX X.^^^^^|||||||\n\n\n\n\n\n\n\nPath report.gross description\n\nA. The specimen is received in a container with 10% formalin, labeled with the\npatient's name and 'rt ex iliac obt node '. The specimen consists of multiple pieces\nof lobulated yellow adipose tissue measuring from 0.9-4.5 cm.The cut surface reveals\n3 lymph nodes ranging in size from 0.3-2.0 cm. The remaining adipose tissue is\nunremarkable.\nThe specimen is submitted in toto, as follows:\n1-2: Large lymph node, trisected\n3: Lymph node, bisected\n4: Lymph node, bisected\n5-8: Remainder of yellow adipose tissue\nB. The specimen is received in a container with 10% formalin, labeled with the\npatient's name and 'lt ext iliac obt node'. The specimen consists of multiple pieces\nof lobulated yellow adipose tissue measuring 1.1-5.0 cm.The cut surface reveals 2\nlymph nodes ranging in size from 1.2- 2.5 cm. The remaining adipose tissue is\nunremarkable.\nThe specimen is submitted in toto, as follows:\n1-3: Largest lymph node, submitted in toto\n4: Lymph node, bisected\n5-10: Remainder of yellow adipose tissue\n\nC. Gross Prostate\nThe specimen is received in a container with 10% formalin, labeled with the\npatient's name and 'prostate'.The specimen consists of a prostate with attached\nRight and Left seminal vesicles. The specimen weight is 25 g after removal of the\nseminal vesicles.\nProstate: Anterior-Posterior 3.1 cm, Right-Left and 4.0 cm, Apex-Base 3.5 cm\nThe surface of the prostate gland is inked:\nLeft surface/seminal vesicle - green\nRight surface/ seminal vesicle - black\nRight seminal vesicle - 3.1 x 1.5 x 0.6 cm\nLeft seminal vesicle- 2.5 x 2.0 x 1.1 cm\nThe surface of the prostate gland is smooth. The cut surface of the prostate gland\nshows pale areas and nodules.\nProstate is submitted in total as follows:\n1: Right Seminal Vesicle\n2: Left Seminal Vesicle\n3: Right Apex\n4-5: Left Apex\n6: Right Base\n7-8: Left Base\nThe sections are submitted from Apex to Base and each slice is submitted as follows:\nRight - Posterior\nLeft - Posterior\nRight - Anterior\nLeft - Anterior\nSlice 1 through slice 10.\n9-10: Slice 1\n11-12: Slice 2\n13-14: Slice 3\n15-16: Slice 4\n17-18: Slice 5\n19-20: Slice 6\n21-22: Slice 7\n23-24: Slice 8\n25-26: Slice 9\n27-28: Slice 10\nTotal 28 blocks.\n(tlj)\n\n\nPath report.microscopic observation\n\n* EXAM: Prostate - Radical Prostatectomy: 1 *\nSpecimen             \n Procedure:            Radical prostatectomy\n Prostate Size:          3.5 x 4 x 3.1 cm\n Weight:              25 g\n Lymph Node Sampling:       Pelvic lymph node dissection\nTumour              \n Histologic Type:         Adenocarcinoma (acinar, not otherwise\n                  specified)\n Histologic Grade:         Gleason Pattern\n  Primary Pattern:        Grade 3\n  Secondary Pattern:       Grade 4\n  Tertiary Pattern:        Not applicable\n  Total Gleason Score:      7\nExtent              \n Tumour Quantitation       \n  Percentage of Prostate Involved by Tumour: 8%\n Extraprostatic Extension:     Not identified\n  Seminal Vesicle Invasion:    Not identified\nMargins:              Margins uninvolved by invasive carcinoma\nAccessory Findings        \n Treatment Effect on Carcinoma:  Not identified\n Lymph-Vascular Invasion:     Not Identified\n Perineural Invasion:       Present\nSpecial Studies          \n Ancillary Studies:        Not performed\nLymph Nodes            \n Number of Lymph Nodes Examined:  15\n Lymph Nodes Involved:       None identified\nStage (pTNM)           \n TNM Descriptors:         m (multiple)\n Primary Tumour (pT):       pT2c: Bilateral disease\n Regional Lymph Nodes (pN):    pN0: No regional lymph node metastasis\n Distant Metastasis (pM):     Not applicable\nAdditional Non-Tumour       \n Additional Pathologic Findings:  High-grade prostatic intraepithelial\n                  neoplasia (PIN) and Inflammation\n* END SECTION: Prostate - Radical Prostatectomy: 1 *\n\n\nPath report.relevant Hx\n\nProstate Ca.\n\n\nPath report.final diagnosis\n\nA. RIGHT EXTERNAL ILIAC OBTURATOR LYMPH NODES, DISSECTION - LYMPH NODES ARE\nNEGATIVE FOR METASTATIC MALIGNANCY (0/8)\nB. LEFT EXTERNAL ILIAC OBTURATOR LYMPH NODES, DISSECTION - LYMPH NODES ARE\nNEGATIVE FOR METASTATIC MALIGNANCY. (0/7)\nC. PROSTATE GLAND, RADICAL PROSTATECTOMY - INVASIVE ADENOCARCINOMA, NOS\n - OVERALL GLEASON'S SCORE: 7 (3+4)\n - NEGATIVE FOR EXTRAPROSTATIC EXTENSION AND SEMINAL VESICLE INVASION\n - LYMPHOVASCULAR INVASION: NOT IDENTIFIED\n - SURGICAL MARGINS ARE CLEAR\n(PLEASE SEE ATTACHED SYNOPTIC REPORT FOR FURTHER DETAILS)\n(CVA)\n\n\nPath report.site of origin\n\nLYMPH NODE - Any location\nLYMPH NODE - Any location\nPROSTATE - GLAND RESECTION\n\n\nPath report.site of origin\n\nA. RIGHT EXTERNAL ILIAC OBTURATOR LYMPH NODE\nB. LEFT EXTERNAL ILIAC OBTURATOR LYMPH NODE\nC. PROSTATE - STITCH AT APEX (URETHRA)\n\n\nPath report.comments\n\n@TICKET # 231780 ,HANDLED BY - DH/TA/DLS\n\n\n"
}